Search

everythinglearnresearchcommunity

for

Search:↓

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Dupilumab effectively treated severe alopecia areata in a child.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Gut bacteria differences may influence alopecia areata.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Gut bacteria differences could help diagnose and treat alopecia areata.

Females have a higher lifetime risk of alopecia areata than males.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

ILC1-like cells can independently cause alopecia areata.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Methotrexate can help some kids with severe hair loss regrow hair.